The efficacy of oral erythromycin in enhancement of milk tolerance in premature infants: A randomized clinical trial

Iranian Journal of Medical Sciences

Volumn 29, Issue 1, 2004, Pages 1-4

  Madani, A ^a,b   Pishva, N ^a   Pourarian, Sh ^a   Zarkesh, M ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Erythromycin; Feeding intolerance; Prematurity

Indexed keywords

ERYTHROMYCIN; IBUPROFEN;

ARTICLE; ARTIFICIAL MILK; BREAST MILK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENTERIC FEEDING; FEMALE; GESTATIONAL AGE; HUMAN; LENGTH OF STAY; MALE; NEWBORN; NUTRITIONAL INTOLERANCE; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT OUTCOME;

EID: 7044247820     PISSN: 02530716     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Boulloche J, Mallet E, Mouterde O, et al: Dystonic reactions with metoclopramide: Is there a risk population? Helv paediater Acta 1987;42: 425-432.
2. Laura P. James: Pharmacology for the gastrointestinal tract. In: Clinics in Perinatology, Saunders, 2002; 29: 115-135.
3. Hill SL, Evangelista JK, Pizzi AM, et al: Proarrhythmia associated with cisapride in children. Pediatr 1998;101: 1053-1056.
4. Khongphatthanayothin A, Lane J, Thomas D, et al: Effects of cisapride on feeding interval in children. J Pediatr 1998;133: 51-56.
5. Simkiss DE, Adams IP, Myrdal U, et al: Erythroenic in neonatal postoperative intestinal dysmotility. Arch Dis Child 1994;71: 128-129.
6. Schanler RJ, Shulan RJ, Lau C, et al: Feeding strategies for premature infants: Randomized trial of Gl priming and tube-feeding method. Pediatrics 1999;103: 434
7. th ed. New York: Lippincott Williams & Wilkins, 1999: 365-382.
8. th ed. St. Louis: Mosby, 2002: 1261-1262.
9. Cothran DS, Borowitz SM, Sutphe JL, et al: Alteration of normal gastric flora in neonates receiving ranitidine. J Perinatal 1997;17: 383-388.
10. Ng PC, Kw So: Randomized controlled study of oral erythromycin for treatment of Gl dysmotility in pereterm infants. Arch Dis Child Fetal Neonatal Ed 2001;84: 177-182.
11. Ng PC, Fok TF, Lee CH, et al: Erythromycin treatment for Gl dysmotility in preterm infants. J Paediatr Child Health 1997;33: 148-150.
12. Kuusela AL: Long- term gastric pH monitoring for determining optimal dose of ranitidine for critically ill preterm and term neonates. Arch Dis Child Fetal Neonatal ed 1998;78: 151-153.
13. Douglas G. Burrin, Barbara Stoll: Nutrients and growth factors for the neonatal Gl tract. Clinics in Perinatology 2002;29: 65-96
14. Honein MA, Paulozzi LJ, Himelright Im, et al: Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromycin: A case review and cohort study. Lancet 1999;354: 2107-2105.
15. Patole SK, Almonte R, Kadalraja R, et al: Can prophylactic oral erythromycin reduce time to full enterai feeds in preterm neonates. Int J Clin Pract 2000;54: 504-8.
16. th ed. New York: Mcgraw-Hill, 2001: 778-781.